Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

Multiomics is revolutionizing biology by enabling breakthroughs in research and disease diagnosis.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

Nanocapsules can improve clobetasol delivery to hair follicles, reducing side effects.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Pesticides can cause reproductive and adrenal health issues.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Chitosan glycolate and lactate sponges are promising for wound healing, while chitosan ascorbate sponges are less effective.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

The research shows how certain drugs can form stable structures with polymers, which is important for making new pharmaceuticals.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Cubosomes improve drug delivery for skin and eye diseases by enhancing adhesion, retention, and release.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Drug misuse can cause serious eye infections and other severe side effects.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Intralesional cidofovir may be a viable treatment for conjunctival lesions in Melkersson-Rosenthal syndrome without systemic toxicity.

Hydrophilic carbon dots cause one protein to clump more and prevent another from clumping.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Vimentin and keratin help viruses spread and could be targets for antiviral treatments.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.